Explore how Genpact is using digital innovation and process expertise to solve environmental sustainability challenges here. About Genpact CDP is a globally recognized disclosure platform that is fully aligned with ISSB's (International Sustainability Standards Board) IFRS2 climate related standard, as its foundational baseline. CDP is used by companies, investors, and other stakeholders to assess environmental impacts, climate risks, and sustainability strategies. In the latest CDP assessment cycle, Genpac ...

Investors interested in stocks from the Computers - IT Services sector have probably already heard of Genpact (G) and Epam (EPAM) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.The best way to find great value stocks is to pair a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies wit ...

Recognition highlights Genpact's AI-first, front-to-back banking operations capabilities across lending, payments, and servicing to deliver banking transformation NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Genpact (NYSE: G), an advanced technology services and solutions company, today announced it has been named a Leader in the Everest Group Banking Operations – Services PEAK Matrix® Assessment 2025. The recognition highlights Genpact's ability to deliver end-to- end banking operations by combining deep domain ...

Brand Finance cites Genpact's double-digit brand value growth in its latest IT services rankings thNEW YORK, Jan. 21, 2026 /PRNewswire/ -- Genpact (NYSE: G), an agentic and advanced technology solutions company, has been ranked as one of the world's most valuable and strongest IT services brands in the 2026 Brand Finance IT Services 25 report. Genpact has emerged as a 'brand to watch' in the ranking, following a 16% increase in brand value to USD 1.5 billion, which pushed the brand up one rank to 18 overal ...

Core Insights - The research by Genpact highlights how leading organizations are leveraging AI to transform operations and achieve growth, focusing on the journey towards becoming an autonomous enterprise where AI is integrated into core workflows [1][2] Enablers of Autonomous Enterprises - Four critical enablers have been identified that set leading organizations apart in their journey to autonomy: the orchestration of end-to-end business processes, democratization of AI fluency, establishment of data-centric foundations, and governance mechanisms for rapid and responsible AI scaling [5][8] Executive Perspectives - A significant portion of senior executives (at least 25%) believe that self-managing business processes with minimal human oversight could be realized within three years, yet only 3% are currently implementing the necessary AI orchestration platforms [2][3] Challenges in AI Adoption - Despite high confidence in AI's potential, many organizations face foundational challenges, including inadequate governance models and workforce capability gaps, with only 45% of companies providing AI training for all employees [3][4] Research Methodology - The findings are based on a global survey of 500 senior executives from organizations with over $1 billion in annual revenue across 13 business functions and 8 industries, supplemented by qualitative interviews with 10 senior executives [6]

Core Viewpoint - The article compares Genpact (G) and Epam (EPAM) to determine which stock is more attractive to value investors, highlighting the importance of various valuation metrics in this assessment [1]. Group 1: Valuation Metrics - Genpact has a forward P/E ratio of 12.12, while Epam has a forward P/E of 17.40, indicating that Genpact may be undervalued compared to Epam [5]. - Genpact's PEG ratio is 1.26, which is lower than Epam's PEG ratio of 2.13, suggesting that Genpact offers better value when considering expected earnings growth [5]. - Genpact has a P/B ratio of 3.25, slightly lower than Epam's P/B of 3.26, further supporting the argument that Genpact is a more attractive value option [6]. Group 2: Earnings Outlook - Both Genpact and Epam hold a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and improving earnings outlooks for both companies [3]. - Despite the positive earnings outlook for both companies, value investors will focus on traditional figures and metrics to assess undervaluation [3]. Group 3: Value Grades - Genpact has earned a Value grade of A, while Epam has a Value grade of C, reinforcing the conclusion that Genpact is the superior value option at this time [6].

Core Viewpoint - Genpact will report its fourth quarter 2025 financial results on February 5, 2026, after market close [1] Group 1: Financial Reporting - The financial results announcement will be followed by a conference call hosted by Genpact's management team at 5:00 p.m. ET [2] - Participants are encouraged to register in advance for a dial-in number and unique PIN for access to the call [2] - A live webcast of the call will be available on the Genpact Investor Relations website, with a replay and transcript posted shortly after the call [2] Group 2: Company Overview - Genpact is recognized as an agentic and advanced technology solutions company, leveraging process intelligence and artificial intelligence [3] - The company aims to deliver measurable outcomes and innovative solutions that transform business operations [3] - Genpact has a strong partner ecosystem and decades of client trust, focusing on client centricity and active learning [3]

Zane Rowe, CFO, Workday: “There has never been a more exciting time to be a CFO, with AI unlocking new opportunities for value creation through unprecedented data and insights. Most of the focus has been on experimentation and discovering the art of the possible, but this year, leaders will shift from ‘What can AI do?’ to ‘How do we build the foundation for scale?’ They will manage a more nuanced AI portfolio that balances launching pilots with rolling out proven solutions, and they will prioritize the ungl ...

Core Viewpoint - Genpact has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system emphasizes the correlation between changes in earnings estimates and stock price movements, suggesting that revisions in earnings estimates are a powerful indicator of near-term stock performance [4][6]. - Genpact's earnings per share (EPS) for the fiscal year ending December 2025 is projected to be $3.62, with no year-over-year change, but the Zacks Consensus Estimate has increased by 2.8% over the past three months, reflecting a positive trend in earnings estimates [8]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 (Strong Buy) stocks historically generating an average annual return of +25% since 1988 [7]. - Genpact's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term due to favorable earnings estimate revisions [10].

Core Viewpoint - Genpact is positioned as a significant player in the professional services sector, focusing on digital transformation and business process management, competing with major firms like Accenture and IBM [1] Company Overview - Genpact provides services across various industries, including banking, insurance, and healthcare, emphasizing innovative solutions to enhance business operations [1] - The company has a market capitalization of approximately $8.28 billion, indicating its substantial presence in the industry [5][6] Stock Performance - As of the latest data, Genpact's stock is priced at $47.33, reflecting a slight decrease of 0.07% with a change of $0.035 [4][6] - The stock has shown volatility over the past year, reaching a high of $56.76 and a low of $37.49 [4] Analyst Ratings - Susquehanna has set a price target of $50 for Genpact, suggesting a potential increase of approximately 5.84% from its current trading price [2][6] - Zacks Investment Research identifies Genpact as a top growth stock for long-term investment, supported by favorable ratings in the Zacks Style Scores [3][6] Market Activity - The trading volume for Genpact on the NYSE is reported at 342,606 shares for the day, indicating active investor interest [5]